SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-18-001120
Filing Date
2018-07-16
Accepted
2018-07-16 19:23:17
Documents
1
Period of Report
2018-06-29

Document Format Files

Seq Description Document Type Size
1 form4-07162018_040701.html 4  
1 form4-07162018_040701.xml 4 3239
  Complete submission text file 0001415889-18-001120.txt   4718
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Issuer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address C/OAZURRX BIOPHARMA,INC.760 PARKSIDE AVE DOWNSTATE BIOTECHNOLOGY INCUBATOR,STE217 BROOKLY NY 11226
Business Address
Riddell Alastair (Reporting) CIK: 0001681349 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37853 | Film No.: 18955314